TYRVAYA (varenicline tartrate)
NASAL PREPARATIONS - NICOTINIC RECEPTOR PARTIAL AGONIST · TEAR FILM INSUFFICIENCY
OYSTER POINT PH
Drug class
Nasal Preparations - Nicotinic Receptor Partial Agonist
The phrase "Nasal Preparations - Nicotinic Receptor Partial Agonist" functions as a formulary and compendial classification rather than a formal FDA Established Pharmacologic Class. Read more about Nasal Preparations - Nicotinic Receptor Partial Agonist
2 drugs in this class 2 manufacturers
Drugs in Nasal Preparations - Nicotinic Receptor Partial Agonist
TYRVAYA (varenicline tartrate)
NASAL PREPARATIONS - NICOTINIC RECEPTOR PARTIAL AGONIST · TEAR FILM INSUFFICIENCY
VIATRIS/HARROW
Filter & compare in the drug finder →
Opens the drug finder with Nasal Preparations - Nicotinic Receptor Partial Agonist preselected. Add indication or manufacturer filters there.
The phrase "Nasal Preparations - Nicotinic Receptor Partial Agonist" functions as a formulary and compendial classification rather than a formal FDA Established Pharmacologic Class.
In clinical practice and drug compendia, this grouping specifically designates intranasally administered nicotinic acetylcholine receptor partial agonists, represented by varenicline nasal solution.
Rather than delivering systemic nicotine replacement, these intranasal preparations bind selectively to nicotinic acetylcholine receptors within the nasal cavity to stimulate the trigeminal parasympathetic pathway.
This neural activation triggers the lacrimal functional unit to enhance endogenous basal tear production, making this medication class uniquely indicated for treating the signs and symptoms of dry eye disease.
-
formularynavigator.com
The phrase "Nasal Preparations - Nicotinic Receptor Partial Agonist" functions as a formulary and compendial classification rather than a formal FDA Established Pharmacologic Class
-
formularynavigator.com
The phrase "Nasal Preparations - Nicotinic Receptor Partial Agonist" functions as a formulary and compendial classification rather than a formal FDA Established Pharmacologic Class
-
fda.gov
The phrase "Nasal Preparations - Nicotinic Receptor Partial Agonist" functions as a formulary and compendial classification rather than a formal FDA Established Pharmacologic Class
-
connectrx.com
In clinical practice and drug compendia, this grouping specifically designates intranasally administered nicotinic acetylcholine receptor partial agonists, represented by varenicline nasal solution
-
webmdrx.com
In clinical practice and drug compendia, this grouping specifically designates intranasally administered nicotinic acetylcholine receptor partial agonists, represented by varenicline nasal solution
-
fda.gov
In clinical practice and drug compendia, this grouping specifically designates intranasally administered nicotinic acetylcholine receptor partial agonists, represented by varenicline nasal solution
-
fda.gov
Rather than delivering systemic nicotine replacement, these intranasal preparations bind selectively to nicotinic acetylcholine receptors within the nasal cavity to stimulate the trigeminal parasympathetic pathway
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.